Feed 206A.T
20
PRISM BioLab Co.,LTD
206A.T · JPX
¥163.00 -2.98% (-¥5.00)
1M +13.51%
Market Cap ¥6.03B
P/E Ratio -
Div. Yield -
ROE 36.37%
Valuation
41 /100
Fair P/B 2.22x
P/S 8.90x
EV/FFO N/A
Growth
64 /100
Stable Book val. growth 17.38%
Rev. growth 6.90%
FCF growth N/A
Profitability
16 /100
Weak Op. margin 114.34%
Gross margin 39.83%
FCF margin 226.34%
Quality
3 /100
Poor ROA 27.02%
ROIC 28.60%
Asset turnover 0.22x
Debt
100 /100
Low Current ratio 8.21x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
11 /100
Unstable EPS volatility 582.64%
Beta 1.43x
Profitable years 0
Vprašajte StockBota o 206A.T
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dai Takehara
Employees
35
Headquarters
Fujisawa
Prihajajoči dogodki
13 NOV.
Earnings
Upcoming earnings report